Research & Development

Myricx announces antibody license agreement with Biocytogen

The two companies have come together on a license agreement to enable Myricx to commercialise ADCs based on an antibody developed using Biocytogen’s proprietary platform

Breaking News

Research presents new approach to discover targets for Alzheimer’s

Recent research has demonstrated that protein phase separation (PPS) is widely present in cells and drives a variety of important biological functions

CPI opens vaccine manufacturing facility in pandemic preparation

A new centre to develop vaccines and therapeutics has opened in Darlington with the capability to develop and manufacture treatments for incurable...

Nulogy and OMP expand supply chain solution partnership

The companies are expanding their partnership, offering their combined solutions and services to additional industries to fulfil their growing need...

How serious is the Pirola strain?

Following the recent news of gradually increasing cases of the new COVID-19 variant Pirola, we sat down with Moderna's VP of Medical Affairs Cesar...

NICE recommends Lilly’s mirikizumab for the treatment of Ulcerative Colitis

Eli Lilly has received the "go ahead" from NICE, the organisation that has recommended its mirikizumab for the treatment of adults with moderately...

Addressing challenges with clinical in-use testing of biotherapeutics

In this article, Lonza discusses the more demanding aspects surrounding clinical in-use testing of biotherapeutic DPs for parenteral delivery while...

Unearthing the potential of CDMO services to accelerate complex biologics development

The biologics landscape continues to transform in response to technological advancements and a growing understanding of molecular biology and bioch...

Adding more to the cell and gene therapy playbook

With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanopartic...

PackGene partners Kudo Bio on customised mRNA manufacturing

The two companies have partnered to develop end-to-end coverage of mRNA development, from gene to mRNA, lipid nanoparticle (LNP) formulation develo...

Phytome moves to develop AI-driven technologies in pharmaceutical agriculture

Phytome Life Sciences has shared the results of research from a collaboration with Inventronics and the University of Plymouth that backs its appli...

Taking a decentralised approach to commercialising cell and gene therapies

With the medical world facing some of the worst cancer drug shortages in history, many thousands of patients are not getting the treatments they ne...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

iotaSciences reveals data to back single-cell picking instrumentation

The company has collaborated with SEISMIC at the University of Surrey to share encouraging data for the use of its single-cell picking instrumentat...

Establishing a rigorous and robust approach to topical drug product process development: part II

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...

Orbit partners Orano on peptide radionuclide therapies

Orbit Discovery and Orano Med have entered a collaboration to discover novel targeted radioligand therapies for cancer treatment

Establishing a rigorous and robust approach to topical drug product process development: part I

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...